SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, will host an investor ...

“We worked so hard to build our life the way it is,” Elmi said, speaking in Somali as Anab Abdi, who functions as an operations manager for the mall, interpreted. Once a radio broadcaster in ...

In this article, we are going to take a look at where AnaptysBio, Inc. (NASDAQ:ANAB) stands against other unstoppable growth stocks to invest in now. BlackRock highlighted that the trade conflict ...

$ANAB insiders have traded $ANAB stock on the open market 4 times in the past 6 months. Of those trades, 3 have been purchases and 1 have been sales. Here’s a ...

AnaptysBio, Inc. (ANAB) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the ...